| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Oncology | $150.56M | $158.69M | $184.4M | $189.95M | $204.95M |
| Biopharma and data | $45.38M | $56.02M | $54.73M | $54.01M | $52.98M |
| Screening | $5.68M | $14.81M | $24.11M | $35.13M | $41.59M |
| Licensing and other | $1.86M | $2.57M | $1.95M | $2.18M | $2.14M |
| Total | $203.47M | $232.09M | $265.2M | $281.27M | $301.67M |